ReviewJournal of pharmacy & bioallied sciences2025
Association of Traumatic Brain Injury with Subsequent Psychiatric and Neurological Conditions: A Meta-Analysis.
Review in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Traumatic Brain Injury and the Road to Alzheimer's Disease.Biomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research aims to evaluate the association between traumatic brain injury (TBI) and the development of subsequent neurological and psychiatric disorders. A comprehensive literature search was conducted using PubMed for studies published from 1995 to 2012. Fifty-seven studies were included based on predefined inclusion criteria. Data were extracted independently by two reviewers, and pooled odds ratios (ORs) with 95% "confidence intervals (CIs)" were calculated using random-effects models. Subgroup analyses based on TBI severity and time intervals between injury and diagnosis were performed. The pooled OR for TBI and the development of any neurological or psychiatric disorder was 1.69 (95% CI 1.46-1.95). TBI increased the risk for neurological disorders (OR 1.57, 95% CI 1.32-1.85) and psychiatric disorders (OR 2.03, 95% CI 1.52-2.70). Parkinson's disease, Alzheimer's disease, bipolar disorder, and depression were all significantly associated with TBI. TBI is a significant risk factor for the development of both neurological and psychiatric disorders. The findings highlight the importance of long-term monitoring of TBI patients to mitigate adverse outcomes and emphasize the need for preventive strategies. Clinical Relevance: This analysis underscores the need for interdisciplinary approaches to manage and prevent long-term complications in TBI survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.